Coronary Artery Disease  >>  eleclazine (GS-6615)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
eleclazine (GS-6615) / Gilead
NCT01847391: A Phase 1 Study to Assess the Safety,Tolerability, and Pharmacokinetics of GS-6615 in Healthy Subjects

Completed
1
36
US
GS-6615, Placebo
Gilead Sciences
Ischemic Heart Disease
11/13
11/13

Download Options